Das Klinikum

Jens Bauer

Telefonnummer: 07071 29-78685

E-Mail-Adresse: j.bauer@uni-tuebingen.de

Goyal*, A., Bauer*, J., Hey*, J., Papageorgiou, D. N., Stepanova, E., Daskalakis, M., Scheid, J., Dubbelaar, M., Klimovich, B., Schwarz, D., Märklin, M., Roerden, M., Lin, Y.-Y., Ma, T., Mücke, O., Rammensee, H.-G., Lübbert, M., Puch, F. L., Krijgsveld, J., Walz#, J. S. and Plass#, C. (2023). "DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts (* and # contributed equally)." Nature Communications
Wacker*, M., Bauer*, J., Wessling, L., Dubbelaar, M., Nelde, A., Rammensee, H.-G. and Walz, J. S. (2023). "Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics (* contributed equally)." Frontiers in Immunology
Bauer, J., Köhler, N., Maringer, Y., Bucher, P., Bilich, T., Zwick, M., Dicks, S., Nelde, A., Dubbelaar, M., Scheid, J., Wacker, M., Heitmann, J. S., Schroeder, S., Rieth, J., Denk, M., Richter, M., Klein, R., Bonzheim, I., Luibrand, J., Holzer, U., Ebinger, M., Brecht, I. B., Bitzer, M., Boerries, M., Feucht, J., Salih, H. R., Rammensee, H.-G., Hailfinger, S. and Walz, J. S. (2022). "The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma." Nature Communications
Bauer, J., Nelde, A., Bilich, T. and Walz, J. (2019). "Antigen Targets for the Development of Immunotherapies in Leukemia." International Journal of Molecular Sciences
Publikationsliste